.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
McKesson
Boehringer Ingelheim
Federal Trade Commission
Colorcon
Merck
AstraZeneca
Cantor Fitzgerald
Mallinckrodt

Generated: December 16, 2017

DrugPatentWatch Database Preview

Methyltestosterone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methyltestosterone and what is the scope of methyltestosterone patent protection?

Methyltestosterone
is the generic ingredient in nine branded drugs marketed by Heather, Impax Labs Inc, Valeant Pharm Intl, Star Pharms Fl, Schering, Novartis, Impax Labs, Lilly, Purepac Pharm, Pvt Form, Tablicaps, Usl Pharma, Valeant Pharms North, Inwood Labs, Kv Pharm, Lannett, Parke Davis, Watson Labs, and West Ward, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for methyltestosterone. Two suppliers are listed for this compound.

Pharmacology for methyltestosterone

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

Medical Subject Heading (MeSH) Categories for methyltestosterone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
NovartisMETANDRENmethyltestosteroneTABLET;BUCCAL, SUBLINGUAL003240-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisMETANDRENmethyltestosteroneTABLET;BUCCAL, SUBLINGUAL003240-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisMETANDRENmethyltestosteroneTABLET;BUCCAL, SUBLINGUAL003240-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ScheringORETONmethyltestosteroneTABLET;BUCCAL080281-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
TablicapsMETHYLTESTOSTERONEmethyltestosteroneTABLET;ORAL085270-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisMETANDRENmethyltestosteroneTABLET;BUCCAL, SUBLINGUAL003240-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm IntlANDROID 5methyltestosteroneTABLET;BUCCAL087222-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Kv PharmMETHYLTESTOSTERONEmethyltestosteroneTABLET;ORAL084312-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs IncMETHYLTESTOSTERONEmethyltestosteroneCAPSULE;ORAL204851-001Sep 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Purepac PharmMETHYLTESTOSTERONEmethyltestosteroneTABLET;ORAL080309-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Mallinckrodt
Citi
UBS
Dow
Chinese Patent Office
Argus Health
Daiichi Sankyo
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot